Price T Rowe Associates Inc Accolade, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Accolade, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 19,540 shares of ACCD stock, worth $73,079. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,540
Previous 16,954
15.25%
Holding current value
$73,079
Previous $204,000
0.49%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ACCD
# of Institutions
173Shares Held
68.8MCall Options Held
163KPut Options Held
492K-
Brown Advisory Inc5.85MShares$21.9 Million0.08% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$21.2 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.61MShares$21 Million0.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$20.2 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY5.33MShares$19.9 Million0.01% of portfolio
About Accolade, Inc.
- Ticker ACCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 71,938,896
- Market Cap $269M
- Description
- Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...